Peptides · Peptide comparison
Acetyl Hexapeptide-3 (Argireline) vs Leuphasyl
SNARE complex inhibitor that reduces expression wrinkles through topical neuromuscular modulation — the 'Botox in a bottle' peptide.
Enkephalin-mimetic cosmetic peptide that reduces expression wrinkles by modulating acetylcholine release at the neuromuscular junction, offering a Botox-like topical alternative.
- Cosmetic
- Cosmetic
At a glance
Quick comparison
Efficacy
Benefit ratings
Expression Wrinkle Reduction
Non-Invasive Treatment
Safety Profile
Wrinkle Reduction
Skin Smoothing
Anti-Aging Prevention
Technical data
Compound specifications
Acetyl Hexapeptide-3 (Argireline)
- Molecular formula
- C35H62N14O11S
- Molecular weight
- 887.0 Da
- Half-life
- Topical stability dependent on formulation; methionine residue susceptible to oxidation; stable at pH 5.5-7.7
- Bioavailability
- Limited skin penetration (0.22-0.54%); primarily acts at stratum corneum and superficial epidermis; O/W emulsions enhance delivery
- CAS number
- 616204-22-9
Leuphasyl
- Molecular formula
- C29H39N5O7
- Molecular weight
- 569.65 g/mol
- Half-life
- Topical application (local activity, systemic half-life not applicable)
- Bioavailability
- Limited (topical peptide; skin penetration challenged by hydrophilic nature and molecular size)
- CAS number
- 64963-01-5
Protocols
Dosing compared
Acetyl Hexapeptide-3 (Argireline)
Topical
- 5-10% concentration (cream or serum)Twice daily (morning and evening) · Minimum 28-30 days; ongoing use to maintain effectUsed as a leave-on skin cream or serum. In studies, a 10% formula applied twice a day around the eyes reduced wrinkle depth by about 17% after 15 days and up to 27-30% after 30 days. It works on the skin surface only and is not injected. [1][2]
Leuphasyl
Topical
- 2% Leuphasyl in formulationOnce or twice daily · 4-8 weeksLowest concentration shown to give significant wrinkle reduction in cosmetic testing; 2% was the threshold at which measurable improvement appeared over ~2 months of daily use [6].
- 5% Leuphasyl in formulationOnce or twice daily · At least 4 weeksManufacturer in-vivo concentration; 5% Leuphasyl reduced wrinkles ~11% after 28 days, and ~25% (up to 47%) when paired with 5% Argireline [6].
Applications
Best suited for
Acetyl Hexapeptide-3 (Argireline)
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals seeking non-invasive reduction of expression lines and dynamic wrinkles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][4].
- Those with needle phobia who want botulinum toxin-like effects without injections
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on those with needle phobia who want botulinum toxin-like effects without injections. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [4].
- People targeting crow's feet, forehead lines, and glabellar creases
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on people targeting crow's feet, forehead lines, and glabellar creases. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
- Acetyl Hexapeptide-3 (Argireline) is particularly well-suited for individuals focused on individuals looking for preventive anti-wrinkle treatment to slow expression line formation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Leuphasyl
- Expression line reduction
- Leuphasyl is particularly well-suited for individuals focused on expression line reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Fine line prevention
- Leuphasyl is particularly well-suited for individuals focused on fine line prevention. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Age management
- Leuphasyl is particularly well-suited for individuals focused on age management. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Non-invasive wrinkle reduction
- Leuphasyl is particularly well-suited for individuals focused on non-invasive wrinkle reduction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Acetyl Hexapeptide-3 (Argireline)
Common
- Mild Skin Irritation
- Transient Redness
- Slight Dryness
- Stinging on Compromised Skin
Uncommon
- Contact Dermatitis
Serious
- Allergic Contact Dermatitis
Leuphasyl
Common
- Mild discomfort at treatment site
- Mild skin tingling
- Mild redness at application site
Uncommon
- Temporary skin dryness
Serious
- Severe allergic reaction
Research status
Safety & evidence
Acetyl Hexapeptide-3 (Argireline)
- Evidence level
- Limited human trials
- FDA status
- Research compound
- Safety overview
- Acetyl Hexapeptide-3 demonstrates an excellent safety profile for topical cosmetic use with no serious adverse events reported in clinical studies. At the 10% concentrations used in cosmetic formulations, systemic absorption is minimal and no neurotoxicity has been observed despite its mechanism of action on the neuromuscular junction. In cell-culture testing, significant cytotoxicity appeared only at concentrations 18 to 10,000 times higher than the reference drug doxorubicin [5]. Primary concerns are limited to local skin irritation in sensitive individuals, such as mild erythema, transient stinging, or contact dermatitis in those with peptide hypersensitivity.
Contraindications
- Known hypersensitivity to acetyl hexapeptide-3 or formulation components
- Active skin infections or open wounds at the application site
- No known systemic contraindications at cosmetic concentrations
- Use with caution in individuals with neuromuscular disorders (theoretical concern)
Leuphasyl
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Leuphasyl (Pentapeptide-18) has been studied in cosmetic research for over 15 years. This topical enkephalin-mimetic peptide demonstrates an excellent safety profile in cosmetic formulations, with no reported serious adverse effects in clinical applications. As a topical cosmetic ingredient, it avoids systemic absorption concerns associated with injectable treatments. The peptide is well-tolerated across all skin types including sensitive skin. Individual responses can vary with formulation and concentration, but most effects are manageable with standard cosmetic application protocols.
Contraindications
- Known hypersensitivity to peptides
- Open wounds or broken skin at application site
- Active dermatological infections at application site
Decision guide
Which is right for you?
Acetyl Hexapeptide-3 (Argireline)
Choose Acetyl Hexapeptide-3 (Argireline) if…
- Individuals seeking non-invasive reduction of expression lines and dynamic wrinkles
- Those with needle phobia who want botulinum toxin-like effects without injections
- People targeting crow's feet, forehead lines, and glabellar creases
- Individuals looking for preventive anti-wrinkle treatment to slow expression line formation
Leuphasyl
Choose Leuphasyl if…
- Expression line reduction
- Fine line prevention
- Age management
- Non-invasive wrinkle reduction